TGFB1 and neoplasm: However, at advanced stages, when cancer cells have acquired oncogenic mutations and/or have lost tumor suppressor gene function, cells are resistant to TGF-β-induced growth arrest, and TGF-β functions as a tumor promotor by stimulating tumor cells to undergo epithelial-mesenchymal transition (EMT) [55].